Study summary

This was a 40-week study to investigate how safe and effective solifenacin solution was in treating children or adolescents with symptoms of overactive bladder (OAB), who completed study 905-CL-076 (NCT01565707).

Additional Study Details

Phase
3
Product
  • Solifenacin succinate suspension
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    148
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A study to investigate how safe and effective Solifenacin solution is in treating children/adolescents with symptoms of overactive bladder (OAB) who completed study 905-CL-076? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site: 6301
      Quezon City, Philippines, 1108
      Completed
      Site: 5202
      Mexico City, Mexico, 4530
      Withdrawn
      Site: 4901
      Marburg, Germany, 35043
      Withdrawn
      Site: 3302
      Lille, France, 59037
      Withdrawn
      Site: 5504
      Campinas, Brazil, 13024-500
      Withdrawn
      Site: 3101
      Nijmegen, Netherlands, 6525 GA
      Withdrawn
      Site: 9104
      Dehradun, India, 248140
      Withdrawn
      Site: 1012
      Phoenix, AZ, United States, 85032
      Withdrawn
      Site: 1014
      Albany, NY, United States, 12208
      Withdrawn
      Site: 9109
      New Delhi, India, 110001
      Withdrawn
      Site: 9102
      Nagpur, India, 440012
      Completed
      Site: 3854
      Kharkiv, Ukraine
      Completed
      Site: 4701
      Bergen, Norway, 5021
      Withdrawn
      Site: 9004
      Kocaeli, Turkey, 41380
      Withdrawn
      Site: 4404
      London, United Kingdom, NW1 2BU
      Withdrawn
      Site: 3103
      Rotterdam, Netherlands, 3015 CE
      Completed
      Site: 4605
      Umea, Sweden, 90185
      Completed
      Site: 9002
      Izmir, Turkey, 35100
      Completed
      Site: 3209
      Antwerp, Belgium, 2650
      Withdrawn
      Site: 4702
      Trondheim, Norway, 7030
      Withdrawn
      Site: 3851
      Kyiv, Ukraine, 58001
      Withdrawn
      Site: 4604
      Stockholm, Sweden, 17176
      Completed
      Site: 4503
      Aalborg, Denmark, DK-9000
      Completed
      Site: 5205
      Mexico City, Mexico, C.P.06700
      Withdrawn
      Site: 5502
      Sao Paulo, Brazil, 05403-000
      Withdrawn
      Site: 3850
      Kiev, Ukraine, 1103
      Withdrawn
      Site: 5505
      Sao Jose do Rio Preto, Brazil, 15090-000
      Completed
      Site: 2703
      Cape Town, South Africa, 7700
      Completed
      Site: 9001
      Ankara, Turkey, 6100
      Completed
      Site: 3201
      Gent, Belgium, 9000
      Withdrawn
      Site: 3206
      Esneux, Belgium, 4130
      Withdrawn
      Site: 7003
      Saint Petersburg, Russian Federation, 194100
      Withdrawn
      Site: 9114
      Jaipur, India, 302004
      Withdrawn
      Site: 4903
      Bonn, Germany, 53105
      Withdrawn
      Site: 5503
      Porto Alegre, Brazil, 90035-003
      Withdrawn
      Site: 8201
      Seoul, Republic of Korea, 120752
      Withdrawn
      Site: 4802
      Wroclaw, Poland, 50-369
      Withdrawn
      Site: 4906
      Frankfurt, Germany, 60435
      Withdrawn
      Site: 1002
      Montreal, Canada, H3H 1P3
      Withdrawn
      Site: 2701
      Johannesburg, South Africa, 1709
      Completed
      Site: 8207
      Seoul, Republic of Korea, 110744
      Completed
      Site: 3202
      Antwerp, Belgium, 2020
      Withdrawn
      Site: 9003
      Ankara, Turkey, 6100
      Withdrawn
      Site: 3105
      Deventer, Netherlands, 7416
      Withdrawn
      Site: 9108
      Ahmedabad, India, 380007
      Completed
      Site: 4603
      Skovde, Sweden, 54185
      Withdrawn
      Site: 1005
      Hamilton, Canada, L8N 3Z5
      Completed
      Site: 3810
      Belgrade, Former Serbia and Montenegro, 11 000
      Withdrawn
      Site: 3104
      Zwolle, Netherlands, 8011 JW
      Completed
      Site: 5507
      Campinas, Brazil, 13087-567
      Withdrawn
      Site: 7002
      Moscow, Russian Federation, 123317
      Completed
      Site: 4801
      Warsaw, Poland, 04-736
      Withdrawn
      Site: 1009
      Durham, NC, United States, 27710
      Withdrawn
      Site: 4402
      Leeds, United Kingdom, LS1 3EX
      Completed
      Site: 3205
      Leuven, Belgium, 3000
      Completed
      Site: 3208
      Charleroi, Belgium, 6000
      Completed
      Site: 5506
      Curitiba, Brazil, 80240-060
      Completed
      Site: 4502
      Kolding, Denmark, 6000
      Completed
      Site: 4606
      Gothenburg, Sweden, 41685
      Completed
      Site: 4804
      Lubin, Poland, 20-093
      Withdrawn
      Site: 1008
      Tarrytown, New York, United States, 10591
      Withdrawn
      Site: 4601
      Jonkoping, Sweden, 55185
      Completed
      Site: 4504
      Koge, Denmark, 4600
      Withdrawn
      Site: 1007
      Stanford, CA, United States, 94305
      Completed
      Site: 3812
      Novi Sad, Former Serbia and Montenegro, 21000
      Withdrawn
      Site: 9005
      Istanbul, Turkey
      Withdrawn
      Site: 3811
      Belgrade, Former Serbia and Montenegro, 11 000
      Completed
      Site: 3204
      Kortrijk, Belgium, 8500
      Withdrawn
      Site: 3301
      Paris, France, 75015
      Completed
      Site: 4602
      Stockholm, Sweden, 11883
      Completed
      Site: 8203
      Daegu, Republic of Korea, 705717
      Completed
      Site: 4403
      Leeds, United Kingdom, LS1 3EX
      Completed
      Site: 1006
      Shreveport, Louisiana, United States, 71106
      Completed
      Site: 4501
      Aarhus N, Denmark, 8200
      Withdrawn
      Site: 3207
      Brussels, Belgium, 1020
      Withdrawn
      Site: 3853
      Dnipropetrovsk, Ukraine, 49100
      Completed
      Site: 3203
      Gent, Belgium, 9000
      Completed
      Site: 8206
      Incheon, Republic of Korea, 400-711
      Completed
      Site: 4803
      Gdansk, Poland, 80-952
      Withdrawn
      Site: 7005
      Moscow, Russian Federation
      Completed
      Site: 4805
      Gdansk, Poland, 80-803
      Withdrawn
      Site: 3210
      Leuven, Belgium, 3000
      Withdrawn
      Site: 1011
      Providence, Rhode Island, United States, 02906
      Withdrawn
      Site: 5203
      Leon, Mexico, 37000
      Withdrawn
      Site: 7001
      Saint Petersburg, Russian Federation, 194100
      Withdrawn
      Site: 9110
      Bangalore, India, 560017
      Withdrawn
      Site: 1015
      Cincinnati, OH, United States, 45229
      Withdrawn
      Site: 7004
      Moscow, Russian Federation, 119991
      Completed
      Site: 4401
      Sheffield, United Kingdom, S10 2TH
      Withdrawn
      Site: 5501
      Santo Andre, Brazil, 090060-650
      Completed
      Site: 1001
      Quebec, Canada, G1V 4G2
      Completed
      Site: 8202
      Seoul, Republic of Korea, 156707
      Withdrawn
      Site: 4902
      Emmendingen, Germany, 79312
      Withdrawn
      Site: 9105
      Hyderabad, India, 500018
      Withdrawn
      Site: 8204
      Gwangju, Republic of Korea, 501757
      Withdrawn
      Site: 5204
      Mexico City, Mexico, 78218

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?